ATE409039T1 - Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839 - Google Patents

Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839

Info

Publication number
ATE409039T1
ATE409039T1 AT04743287T AT04743287T ATE409039T1 AT E409039 T1 ATE409039 T1 AT E409039T1 AT 04743287 T AT04743287 T AT 04743287T AT 04743287 T AT04743287 T AT 04743287T AT E409039 T1 ATE409039 T1 AT E409039T1
Authority
AT
Austria
Prior art keywords
azd2171
combination therapy
human
against cancer
cancer diseases
Prior art date
Application number
AT04743287T
Other languages
English (en)
Inventor
Stephen Wedge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE409039T1 publication Critical patent/ATE409039T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT04743287T 2003-07-10 2004-07-08 Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839 ATE409039T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0316127.0A GB0316127D0 (en) 2003-07-10 2003-07-10 Combination therapy

Publications (1)

Publication Number Publication Date
ATE409039T1 true ATE409039T1 (de) 2008-10-15

Family

ID=27741907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743287T ATE409039T1 (de) 2003-07-10 2004-07-08 Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839

Country Status (23)

Country Link
US (2) US20060167024A1 (de)
EP (1) EP1653964B1 (de)
JP (1) JP2007526888A (de)
KR (1) KR20060033785A (de)
CN (1) CN100415236C (de)
AT (1) ATE409039T1 (de)
AU (1) AU2004255024B2 (de)
BR (1) BRPI0412408A (de)
CA (1) CA2531620C (de)
DE (1) DE602004016754D1 (de)
DK (1) DK1653964T3 (de)
ES (1) ES2313033T3 (de)
GB (1) GB0316127D0 (de)
HR (1) HRP20080597T3 (de)
IL (1) IL172683A0 (de)
MX (1) MXPA06000412A (de)
NO (1) NO20056170L (de)
NZ (1) NZ544270A (de)
PL (1) PL1653964T3 (de)
PT (1) PT1653964E (de)
SI (1) SI1653964T1 (de)
WO (1) WO2005004872A1 (de)
ZA (1) ZA200600184B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008269D0 (en) 2000-04-05 2000-05-24 Astrazeneca Ab Combination chemotherapy
GB0218526D0 (en) * 2002-08-09 2002-09-18 Astrazeneca Ab Combination therapy
GB0310401D0 (en) * 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent
BRPI0508959A (pt) * 2004-03-23 2007-08-14 Astrazeneca Ab uso de azd2171 ou de um sal do mesmo farmaceuticamente aceitável, uso de sal maleato de azd2171 e oxaliplatina, composição farmacêutica, kit, e, método para a produção de um efeito antiangiogênico e/ou de redução da permeabilidade vascular em um animal de sangue quente
GB0406445D0 (en) * 2004-03-23 2004-04-28 Astrazeneca Ab Combination therapy
EP1901754A2 (de) * 2005-07-06 2008-03-26 AstraZeneca AB Kombinationstherapie gegen krebs mit azd2171 und gemcitabin
KR20080077678A (ko) * 2005-12-22 2008-08-25 아스트라제네카 아베 Ａｚｄ2171 및 페메트렉시드의 조합물
WO2009118560A1 (en) * 2008-03-28 2009-10-01 Astrazeneca Ab Combination therapy 038
EP2113255A1 (de) * 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Zytotoxisches Immunglobulin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518341A (ja) * 1998-06-15 2002-06-25 アーチ・デヴェロップメント・コーポレイション 放射線療法と抗血管形成因子の組み合わせ
EE05345B1 (et) * 1999-02-10 2010-10-15 Astrazeneca Ab Kinasoliini derivaadid angiogeneesi inhibiitoritena
ES2243466T3 (es) * 2000-03-31 2005-12-01 Angiogene Pharmaceuticals Ltd Terapias en dosis divididas con actividad dañina vascular.
GB0008269D0 (en) * 2000-04-05 2000-05-24 Astrazeneca Ab Combination chemotherapy
AU2002223684A1 (en) * 2000-11-22 2002-06-03 Novartis Pharma Gmbh Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
EP2292615A1 (de) * 2002-02-01 2011-03-09 AstraZeneca AB Chinazoline Verbindungen

Also Published As

Publication number Publication date
MXPA06000412A (es) 2006-03-17
EP1653964B1 (de) 2008-09-24
SI1653964T1 (sl) 2009-02-28
GB0316127D0 (en) 2003-08-13
CA2531620C (en) 2011-09-27
NO20056170L (no) 2006-02-08
AU2004255024B2 (en) 2007-09-27
HRP20080597T3 (en) 2008-12-31
CN100415236C (zh) 2008-09-03
NZ544270A (en) 2007-09-28
DE602004016754D1 (de) 2008-11-06
KR20060033785A (ko) 2006-04-19
ES2313033T3 (es) 2009-03-01
IL172683A0 (en) 2006-04-10
US20100179142A1 (en) 2010-07-15
ZA200600184B (en) 2007-04-25
PL1653964T3 (pl) 2009-01-30
EP1653964A1 (de) 2006-05-10
HK1089667A1 (en) 2006-12-08
US20060167024A1 (en) 2006-07-27
AU2004255024A1 (en) 2005-01-20
CA2531620A1 (en) 2005-01-20
BRPI0412408A (pt) 2006-08-22
JP2007526888A (ja) 2007-09-20
DK1653964T3 (da) 2009-01-05
CN1819831A (zh) 2006-08-16
PT1653964E (pt) 2008-11-24
WO2005004872A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
SI1551409T1 (sl) Uporaba kinazolinskega derivata ZD6474, kombiniranega z gemcitabinom in po želji ionizirajočim obsevanjem, pri zdravljenju raka
CY1111547T1 (el) Συνδυασμος zd6474 και πεμετρεξεδης
MXPA04004355A (es) Tratamiento de combinacion que comprende zd6474 y un taxano.
CY1111482T1 (el) Συνδυασμος azd2171 και πεμετρεξεδης
MX2007003506A (es) Terapia de combinacion de cancer que comprende azd2171 e imatinib.
MX2007003505A (es) Combinacion que comprende zd6474 e imatinib.
MXPA05008583A (es) Terapia de combinacion de zd6474 con 5-fu y/o cpt-11.
DE602004016754D1 (de) Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839
NO20064755L (no) Kombinasjonsterapi
ATE447973T1 (de) Kombinationstherapie mit azd-2171
NO20056171L (no) Kombinasjonsterapi
WO2005092384A3 (en) Combination therapy with azd2171 and a platinum anti-tumour agent
DE60308403D1 (de) Kombinationstherapie mit gemzitabin und zd6126

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1653964

Country of ref document: EP